Phathom Pharmaceuticals I... (PHAT)
NASDAQ: PHAT
· Real-Time Price · USD
11.71
-0.19 (-1.60%)
At close: Sep 24, 2025, 3:59 PM
11.71
0.00%
Pre-market: Sep 25, 2025, 08:09 AM EDT
-1.60% (1D)
| Bid | 11.11 |
| Market Cap | 830.75M |
| Revenue (ttm) | 114.04M |
| Net Income (ttm) | -330.15M |
| EPS (ttm) | -4.67 |
| PE Ratio (ttm) | -2.51 |
| Forward PE | -38.39 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 11.8 |
| Volume | 1,179,064 |
| Avg. Volume (20D) | 1,093,853 |
| Open | 11.92 |
| Previous Close | 11.90 |
| Day's Range | 11.35 - 12.05 |
| 52-Week Range | 2.21 - 19.50 |
| Beta | 0.44 |
| Ex-Dividend Date | n/a |
About PHAT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PHAT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PHAT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsPhathom Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+90.19%
Phathom Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
4 months ago
-17.86%
Phathom Pharmaceuticals shares are trading lower after HC Wainwright maintained a Buy rating on the stock and lowered its price target from $28 to $20.
1 month ago · seekingalpha.com
Phathom Pharmaceuticals, Inc. (PHAT) Q2 2025 Earnings Call TranscriptPhathom Pharmaceuticals, Inc. (NASDAQ:PHAT ) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET Company Participants Eric Sciorilli - Corporate Participant Robert Breedlove - VP of Finance & P...
